Question 1

What is Bladder cancer?

Accepted Answer

Bladder cancer is a malignancy that most commonly originates in the urothelial cells lining the inside of the bladder, and is classified by how deeply it has grown into the bladder wall (non-muscle-invasive versus muscle-invasive) and by the aggressiveness of the cancer cells (grade). These two factors together guide every subsequent clinical decision.

Question 2

What are the symptoms and health risks of Bladder cancer?

Accepted Answer

The most frequently reported symptom is blood in the urine (haematuria), which may be visible to the naked eye or detectable only on laboratory testing; other symptoms can include a persistent urge to urinate, pain or burning during urination, and, in more advanced disease, pelvic pain or back pain. Some individuals have no noticeable symptoms in the early stages, and haematuria has many potential causes beyond cancer. Symptoms alone are never sufficient to establish or exclude a diagnosis — formal clinical and pathological evaluation is always required.

Question 3

How is Bladder cancer diagnosed?

Accepted Answer

Diagnosis typically begins with a urine analysis and urine cytology (examining shed cells under a microscope), followed by cystoscopy — a direct visual inspection of the bladder interior using a thin, flexible or rigid scope. If suspicious tissue is identified, a transurethral resection of the bladder tumour (TURBT) is performed both to obtain a biopsy and, for superficial tumours, as an initial treatment; the resulting pathology report establishes the tumour grade and the depth of invasion, which are then used alongside CT urography or MRI to assign a clinical stage (typically using the TNM system). The combination of stage and grade determines the individual's risk category and informs which treatment options are most appropriate.

Question 4

How is Bladder cancer treated?

Accepted Answer

Treatment is highly individualised and depends on the tumour's stage, grade, and the patient's overall health. Non-muscle-invasive bladder cancer is often managed with endoscopic resection followed by intravesical therapy (medicines instilled directly into the bladder), while muscle-invasive or high-risk disease generally requires more intensive intervention. For eligible patients with muscle-invasive bladder cancer, radical cystectomy — the surgical removal of the bladder, performed as an open or robotic-assisted procedure — combined with neoadjuvant (pre-operative) chemotherapy represents a standard-of-care approach, though bladder-sparing strategies and systemic therapies are also considered in carefully selected cases.

Question 5

Can Bladder cancer be treated without a procedure?

Accepted Answer

Non-surgical options play a meaningful role in bladder cancer management and include intravesical immunotherapy (most commonly BCG instilled into the bladder) or intravesical chemotherapy for non-muscle-invasive disease, as well as systemic chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapies for advanced or metastatic disease. Bladder-preserving trimodality therapy — combining maximal TURBT, radiation, and concurrent chemotherapy — is an established alternative to cystectomy for selected patients with muscle-invasive disease who are not surgical candidates or prefer to avoid bladder removal. Active surveillance with regular cystoscopy is appropriate for carefully monitored low-risk cases, but a qualified clinician must assess whether any non-surgical pathway is suitable for a given individual.

Question 6

When is Robotic-assisted radical cystectomy considered for Bladder cancer?

Accepted Answer

Robotic-assisted radical cystectomy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

Question 7

Which doctor treats Bladder cancer?

Accepted Answer

Bladder cancer is primarily evaluated and managed by a urologist — specifically one with subspecialty expertise in urological oncology — and, for advanced or complex cases, by a multidisciplinary team that typically includes a medical oncologist (for systemic and intravesical therapies) and a radiation oncologist (when bladder-preserving chemoradiation is considered). Uro-oncology nurse specialists and pathologists with genitourinary expertise are also important members of a comprehensive care team.

Question 8

How do I choose a doctor for Bladder cancer?

Accepted Answer

When selecting a provider for bladder cancer treatment, it is worth asking about the surgeon's or centre's volume of TURBT procedures and radical cystectomies (including robotic-assisted cases), whether a dedicated multidisciplinary uro-oncology tumour board reviews cases, and what follow-up surveillance protocols are in place — since bladder cancer has a notable recurrence rate that requires long-term monitoring. Accreditation of the facility and access to the full range of treatment options, from intravesical therapy through to robotic surgery and systemic oncology, are also practical factors to compare.

Question 9

What documents do international patients need to share for a medical evaluation?

Accepted Answer

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Question 10

How does GAF Healthcare help international patients plan treatment in India?

Accepted Answer

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.

Best Urologists for Robotic-Assisted Radical Cystectomy in India

About Robotic-assisted radical cystectomy doctors in India

Robotic-assisted radical cystectomy doctors

Dr. Anil Mandhani

Dr. Ankit Goel

Dr. Mallikarjuna Reddy N

Dr. Manish C A

Dr. Piyush Singhania

Dr. Rajat Arora

Dr. Suri Babu

Hospitals where these doctors practise

Fortis Memorial Research Institute

Artemis Hospital

Medicover Hospital Hitec City

Apollo Hospital, Bannerghatta Road

Fortis Hospital, Shalimar Bagh

Why consider treatment in India?

More affordable estimates

Internationally accredited hospitals

Experienced specialists

Care coordination support

What is Robotic-assisted radical cystectomy?

Who may be considered?

How does it work?

Robotic-Assisted Radical Cystectomy with Ileal Conduit

Comprehensive Investigations

Treatment / Procedure Estimate

Stay in India

Usually Included in Hospital Package

Usually Not Included

Recovery and follow-up

Risks

Alternatives

What we need to prepare a formal estimate

Reports required

Patient information needed

Want a formal estimate?

How this directory is built

Need help with the next step?

FAQs about Robotic-assisted radical cystectomy in India